CoolClinical.com has Developed the First AI System for Predicting Outcomes of Cancer Treatment

Cool Clinical announced the release of the publication on the first Artificial Intelligence system for predicting outcomes of cancer treatment, using data from clinical trials. This is a breakthrough for AI approaches to cancer treatment, because clinical trial data are widely available; this research therefore shows the way for precision medicine systems for cancer which are very feasible to develop.

The subject was treatment of prostate cancer by the common drug bicalutamide ("Casodex"). Treatment outcomes were predicted two years in advance, based on data collected at the start of treatment in 3653 patients. While the research was focused on prostate cancer, the techniques are generally applicable.

"What we have been able to achieve using Artificial Intelligence is almost like magic," says Dr Felix Beacher, Founder of Cool Clinical. "Responses to drugs vary greatly. But by predicting treatment outcomes, we could select the right drug for a particular patient. This could dramatically improve the safety and effectiveness of drugs, even without making any changes to them. This is the essence of precision medicine."

"Some have suggested that this kind of approach could be a threat to drug companies. I don't think that's true. Companies who embrace this kind of innovation have a great opportunity. Such AI-based approaches are the future. Nothing can change that. These kinds of approaches will sharpen competition and drive innovation in medicine. That's entirely a positive thing, because ultimately it will benefit patients."

The research has just been published in the journal Algorithms, 5 May 2021.
https://www.mdpi.com/1999-4893/14/5/147 (early access version)
https://www.mdpi.com/1999-4893/14/5/147/pdf (full pdf)

About CoolClinical.com

Cool Clinical is a consortium of clinical and computational scientists, dedicated to developing Artificial Intelligence (AI) approaches to cancer. To learn more, please visit www.coolclinical.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...